Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Mari Asada"'
Autor:
Nozomu Shima, Atsuhiro Ogawa, Seiya Kato, Mari Asada, Kyohei Miyamoto, Tsuyoshi Nakashima, Seiji Anai, Mami Shibata
Publikováno v:
Irish Journal of Medical Science (1971 -). 191:355-357
Despite a growing volume of literature on post-intensive care syndrome, we know little about how subjective symptoms affect intensive care unit survivors in the long term. This study aimed to elucidate the prevalence of subjective symptoms and to det
Autor:
Tomoyuki Fujii, Ayumi Taguchi, Yutaka Osuga, Hiroshi Nagabukuro, Yasushi Hirota, Arisa Takeuchi, Osamu Wada-Hiraike, Kaori Koga, Erina Satake, Tetsuya Hirata, Miyuki Harada, Tomoko Makabe, Mariko Miyashita, Mari Asada
Publikováno v:
Molecular Human Reproduction
Non-hormonal therapeutic strategies for endometriosis are needed. The aim of this study was to characterize the effects of prostaglandin (PG)E2 receptor inhibitors to explore their potential as novel therapeutic strategies for endometriosis. The expr
Autor:
Tatsuya Watanabe, Atsushi Kiba, Yusuke Nakayama, Megumi Yanokura, Mari Asada, Daisuke Aoki, Kouji Banno
Publikováno v:
Journal of Obstetrics and Gynaecology Research. 42:1734-1743
Aim Micro ribonucleic acids (miRNAs) play an important pathological role in endometriosis. Leuprolide acetate, an analog of gonadotropin-releasing hormone, is widely used to treat endometriosis; however, the molecular mechanisms involved in endometri
Autor:
Yusuke Nakayama, Tatsuya Watanabe, Megumi Yanokura, Atsushi Kiba, Mari Asada, Daisuke Aoki, Kouji Banno
Publikováno v:
Journal of Obstetrics and Gynaecology Research. 41:1598-1606
Aim Leuprolide acetate, an analog of gonadotropin-releasing hormone (GnRH), regresses endometriotic tissue and reduces pain, resulting in clinical improvement upon treatment. The molecular mechanisms involved in the regression of endometriotic tissue
Autor:
Atsushi, Kiba, Kouji, Banno, Megumi, Yanokura, Mari, Asada, Yusuke, Nakayama, Daisuke, Aoki, Tatsuya, Watanabe
Publikováno v:
The journal of obstetrics and gynaecology research. 42(12)
Micro ribonucleic acids (miRNAs) play an important pathological role in endometriosis. Leuprolide acetate, an analog of gonadotropin-releasing hormone, is widely used to treat endometriosis; however, the molecular mechanisms involved in endometriotic
Autor:
Atsushi, Kiba, Kouji, Banno, Megumi, Yanokura, Mari, Asada, Yusuke, Nakayama, Daisuke, Aoki, Tatsuya, Watanabe
Publikováno v:
The journal of obstetrics and gynaecology research. 41(10)
Leuprolide acetate, an analog of gonadotropin-releasing hormone (GnRH), regresses endometriotic tissue and reduces pain, resulting in clinical improvement upon treatment. The molecular mechanisms involved in the regression of endometriotic tissue, ho
Autor:
Mari Asada, Shoji Fukusumi, Chieko Kitada, Yuji Kawamata, Yoshio Matsumoto, Takanori Yamamoto, Masaki Tanaka, Yasuko Terao, Tsutomu Kurokawa, Takahiko Yano, Takuya Watanabe, Kuniko Kikuchi, Masahiko Fujino, Osamu Nishimura, Yasushi Shintani, Haruo Onda, Yasuhiko Ibata, Shuji Hinuma, Ryo Fujii, Norio Iijima, Masaki Hosoya, Yugo Habata
Publikováno v:
Nature Cell Biology. 2:703-708
Only a few RFamide peptides have been identified in mammals, although they have been abundantly found in invertebrates. Here we report the identification of a human gene that encodes at least three RFamide-related peptides, hRFRP-1-3. Cells transfect
Autor:
Shohei Maekawa, Kazushige Hamada, Rie Tatsumi, Tetsuo Ueda, Mikiko Kobayashi, Mari Asada-Kubota, Yoshihiro Sokawa
Publikováno v:
Journal of Interferon & Cytokine Research. 18:71-74
Type I interferons (IFNs) have been used for the treatment of viral hepatitis, but it is unclear which cells in the liver are affected by injected IFN. The effects of IFN have been studied by the production of 2',5'-oligoadenylate synthetase (2'5'OAS
Autor:
Daisuke Nakata, Yumiko Akinaga, Kazuhiro Miwa, Reiko Sasada, Masami Kusaka, Tsuneo Masaki, Mari Asada, Michiyasu Takeyama, Mie Yoshimatsu, Akira Tanaka, Tatsuya Watanabe
Publikováno v:
European journal of pharmacology. 723
TAK-385 (relugolix) is a novel, non-peptide, orally active gonadotropin-releasing hormone (GnRH) antagonist, which builds on previous work with non-peptide GnRH antagonist TAK-013. TAK-385 possesses higher affinity and more potent antagonistic activi
Publikováno v:
Journal of Interferon & Cytokine Research. 15:863-867
2',5'-Oligoadenylate synthetase (2-5OAS), an enzyme induced by interferon (IFN), has also been found in various "normal" animals that had not been treated with IFN. The distribution of this enzyme in the digestive tracts of normal healthy mice was st